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The term retinitis pigmentosa (RP) refers to bone spicule-
like pigmentation in the mid-peripheral fundus that stimulates 
inflammation and was first used by the German physician 
Donders in 1857 [1]. RP is a progressive rod-cone dystrophy 
that primarily affects the rod photoreceptors whereas the 
function of the cone receptors is compromised as the disease 
progresses [2]. Ocular findings comprise atrophic changes 
in the photoreceptors and in the retinal pigment epithelium 
(RPE) followed by the appearance of melanin-containing 
structures in the retinal vascular layer [2]. The typical fundus 
appearance includes attenuated arterioles, bone spicule-like 
pigmentation, and waxy pallor of the optic disc. Affected 
individuals often have severely abnormal or non-detectable 
rod responses in electroretinogram (ERG) recordings even in 
the early stage of the disease [2].
RP is the most common inherited retinal dystrophy, 
affecting approximately 1 in 5,000 individuals worldwide 
[3]. RP is clinically and genetically heterogeneous, which is 
inherited as a dominant, recessive, as well as an X-linked trait 
[4]. RP presents intra- and interfamilial variations in expres-
sivity, penetrance, progression, and age of onset [5]. Among 
the several causes of variable phenotypes are alternative 
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Purpose: This study was conducted to localize and identify causal mutations associated with autosomal recessive 
retinitis pigmentosa (RP) in consanguineous familial cases of Pakistani origin.
Methods: Ophthalmic examinations that included funduscopy and electroretinography (ERG) were performed to confirm 
the affectation status. Blood samples were collected from all participating individuals, and genomic DNA was extracted. 
A genome-wide scan was performed, and two-point logarithm of odds (LOD) scores were calculated. Sanger sequencing 
was performed to identify the causative variants. Subsequently, we performed whole exome sequencing to rule out the 
possibility of a second causal variant within the linkage interval. Sequence conservation was performed with alignment 
analyses of PDE6A orthologs, and in silico splicing analysis was completed with Human Splicing Finder version 2.4.1.
Results: A large multigenerational consanguineous family diagnosed with early-onset RP was ascertained. An ophthal-
mic clinical examination consisting of fundus photography and electroretinography confirmed the diagnosis of RP. A 
genome-wide scan was performed, and suggestive two-point LOD scores were observed with markers on chromosome 
5q. Haplotype analyses identified the region; however, the region did not segregate with the disease phenotype in the 
family. Subsequently, we performed a second genome-wide scan that excluded the entire genome except the chromo-
some 5q region harboring PDE6A. Next-generation whole exome sequencing identified a splice acceptor site mutation 
in intron 16: c.2028–1G>A, which was completely conserved in PDE6A orthologs and was absent in ethnically matched 
350 control chromosomes, the 1000 Genomes database, and the NHLBI Exome Sequencing Project. Subsequently, we 
investigated our entire cohort of RP familial cases and identified a second family who harbored a splice acceptor site 
mutation in intron 10: c.1408–2A>G. In silico analysis suggested that these mutations will result in the elimination of 
wild-type splice acceptor sites that would result in either skipping of the respective exon or the creation of a new cryptic 
splice acceptor site; both possibilities would result in retinal photoreceptor cells that lack PDE6A wild-type protein.
Conclusions: we report two splice acceptor site variations in PDE6A in consanguineous Pakistani families who mani-
fested cardinal symptoms of RP. Taken together with our previously published work, our data suggest that mutations in 
PDE6A account for about 2% of the total genetic load of RP in our cohort and possibly in the Pakistani population as well.
Correspondence to: S. Amer Riazuddin, The Wilmer Eye Institute, 
Johns Hopkins University School of Medicine, 600 N. Wolfe Street, 
Maumenee 840, Baltimore, MD 21287; Phone: (410) 955-3656; FAX: 
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alleles, environmental factors, modifier genes, or a combina-
tion of these factors [6,7]. Autosomal recessive RP (arRP) 
is the most common form of RP worldwide, and to date, 36 
genes/loci have been associated with autosomal recessive RP 
(RetNet).
Phosphodiesterase 6 (PDE6) is a critical enzyme of the 
visual phototransduction cascade in the vertebrate retina 
[8,9]. The protein is a heterotrimer that consists of an alpha, 
a beta, and two gamma subunits. PDE6A (Gene ID: 5145; 
OMIM: 180071) encodes for the α-subunit of cyclic guanosine 
monophosphate (cGMP)-phosphodiesterase that is primarily 
expressed in rod photoreceptors [10,11]. PDE6A consists of 22 
coding exons and encodes for 860 amino acids [12,13]. Dryja 
and colleagues were the first to report causal mutations in 
PDE6A in patients with arRP [14].
We previously reported three mutations in PDE6A 
including a splice acceptor site mutation in three families of 
Pakistani origin [15]. Here, we report two additional familial 
cases with multiple members manifesting symptoms of RP. 
The clinical phenotype was established with fundus photog-
raphy and electroretinography while genome-wide linkage 
analyses localized the disease interval to chromosome 5q. 
Subsequently, Sanger sequencing identified splice acceptor 
site mutations in these two families that were absent in ethni-
cally matched control chromosomes.
METHODS
Clinical ascertainment: A total of >300 consanguineous Paki-
stani families with non-syndromic retinal dystrophies were 
recruited to identify new disease loci responsible for inherited 
visual diseases. The institutional review boards (IRBs) of the 
National Centre of Excellence in Molecular Biology (Lahore, 
Pakistan), National Eye Institute (Bethesda, MD), and Johns 
Hopkins University (Baltimore, MD) approved the study. 
All participating family members provided informed written 
consent that has been endorsed by the respective IRBs and 
is consistent with the tenets of the Declaration of Helsinki.
A detailed clinical and medical history was obtained 
from the individual families. Funduscopy was performed 
at Layton Rehmatulla Benevolent Trust (LRBT) Hospital 
(Lahore, Pakistan). ERG measurements were recorded by 
using equipment manufactured by LKC (Gaithersburg, 
MD). Dark-adapted rod responses were determined through 
incident flash attenuated with −25 dB, whereas the rod–
cone responses were measured at 0 dB. The 30 Hz flicker 
responses were recorded at 0 dB to a background illumination 
of 17 to 34 cd/m2.
All participating members voluntarily provided approxi-
mately 10 ml of blood sample that was stored in 50 ml 
Sterilin® falcon tubes containing 400 µl of 0.5 M EDTA. 
Blood samples were stored at −20 °C for long-term storage.
Genomic DNA extraction: Genomic DNA was extracted 
from white blood cells using a non-organic modified proce-
dure as described previously [16,17]. Approximately, 10 ml 
blood samples were mixed with 35 ml of TE buffer (10 mM 
Tris-HCl, 2 mM EDTA, pH 8.0) and the TE-blood mixture 
was centrifuged at 2,000 x g for 20 min. The red blood cells 
were discarded and the pellet was re-suspended in 35 ml of 
TE buffer. The TE washing was repeated for 2–3 times and 
the washed pellet was re-suspended in 2 ml of TE buffer. 
Next, 6.25 ml of protein digestion cocktail (50 μl [10 mg/ml] 
of proteinase K, 6 ml TNE buffer [10 mM Tris HCl, 2 mM 
EDTA, 400 mM NaCl] and 200 μl of 10% sodium dodecyl 
sulfate) was added to the re-suspended pellets and incubated 
overnight in a shaker (250 rpm) at 37 °C. The digested proteins 
were precipitated by adding 1 ml of 5 M NaCl, followed by 
vigorous shaking and chilling on ice for 15 min. The precipi-
tated proteins were pelleted by centrifugation at 2,000 x g for 
20 min and removed. The supernatant was mixed with equal 
volumes of phenol/chloroform/isoamyl alcohol (25:24:1) and 
the aqueous layer containing the genomic DNA was carefully 
collected. The DNA was precipitated with isopropanol and 
pelleted by centrifugation at 3,500 x g for 15 min. The DNA 
pellets were washed with 70% ethanol and dissolved in TE 
buffer. The concentration of the extracted genomic DNA was 
estimated with a SmartSpec plus Bio-Rad Spectrophotometer 
(Bio-Rad, Hercules, CA).
Genotype analysis: Applied Biosystems MD-10 linkage 
mapping panels (Foster City, CA) were used to complete the 
genome-wide scan for family PKRP133. Multiplex PCR was 
completed as described previously [15]. The PCR products 
were mixed with a loading cocktail that contained HD-400 
size standards (Applied Biosystems) and were resolved in an 
Applied Biosystems 3100 DNA Analyzer. Genotypes were 
assigned using the GeneMapper software from Applied 
Biosystems. Exclusion analyses were completed for PKRP140 
using closely spaced short tandem repeat (STR) markers. The 
sequence of the primer pairs used for the exclusion analyses 
and amplification conditions are available upon request.
Linkage analysis: Linkage analysis was performed with 
the alleles of PKRP133 obtained through the genome-wide 
scan and the alleles of PKRP140 obtained through exclusion 
analysis using the FASTLINK version of MLINK from the 
LINKAGE Program Package [18,19]. Maximum logarithm 
of odds (LOD) scores were calculated using ILINK from the 
LINKAGE Program Package. arRP was investigated as a 
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fully penetrant disorder that has an affected allele frequency 
of 0.001.
Mutation screening: Primer pairs to amplify the coding exons 
along with exon-intron boundaries of PDE6A were designed 
using primer3 program and are available upon request. PCR 
amplification consisted of a denaturation step at 95 °C for 5 
min followed by a two-step touchdown procedure. The first 
step of 10 cycles consisted of denaturation at 95 °C for 30 
s, followed by primer set specific (available upon request) 
annealing for 30 s (annealing temperature decrease by 1 °C 
per cycle) and elongation at 72 °C for 45 s. The second step of 
30 cycles consisted of denaturation at 95 °C for 30 s followed 
by annealing (annealing 10 °C below the primer set specific 
annealing temperature) for 30 s and elongation at 72 °C for 45 
s, followed by final elongation at 72 °C for 5 min.
The PCR primers for each exon were used for bidirec-
tional sequencing using the BigDye Terminator Ready reac-
tion mix according to the manufacturer’s instructions. The 
sequencing products were resolved on an ABI PRISM 3100 
DNA analyzer (Applied Biosystems), and the results were 
analyzed with Applied Biosystems SeqScape software.
Exome sequencing and variant identification: Exome capture 
library preparation, next-generation sequencing, and variant 
calling were completed commercially at the Cincinnati Chil-
dren’s Hospital and Medical Center (CCHMC) core facility. 
Genomic DNA was captured with the Agilent SureSelect 
Human All Exon kit according to the manufacturer’s instruc-
tions (Agilent, Palo Alto, CA). After capture and enrichment, 
the whole exome paired-end library was sequenced on the 
Illumina HiSeq 2000 Genome Analyzer (Illumina Inc., San 
Diego, CA). Approximately 75% of the reads were aligned 
to the reference sequence and passed quality-control filters, 
which was sufficient to generate on average 30X coverage 
for the exome.
The raw data was mapped to the University of California, 
Santa Cruz (UCSC) hg19 reference genome by ELAND; SNP 
and INDEL (insertion/deletion) calls were made according to 
the genome analysis toolkit (GATK) in exome sequencing and 
variant identification section. The whole exome data consisted 
on average of nearly 27,000 single-base changes. First, we 
removed all variants that were not present in the linkage 
interval. Then, we removed all alleles that were heterozygous 
for the reference allele in the affected individual. Finally, we 
excluded all single nucleotide polymorphisms (SNPs) with a 
minor-allele frequency (MAF) >2% in the affected individual.
In silico analysis: The degree of evolutionary conservation 
of positions at which mutations exist in other PDE6A ortho-
logs was examined using the UCSC Genome browser. The 
effect of the c.1408–2A>G and c.2028–1G>A mutations on 
the PDE6A mRNA splicing was predicted with an online 
bioinformatics tool, the Human Splicing Finder 2.4.1 (HSF).
RESULTS
PKRP133 was recruited from the Punjab province of Paki-
stan. A total of 23 individuals including five affected indi-
viduals were enrolled in the study (Figure 1). Medical records 
and clinical reports of earlier examinations by the family 
physician suggested retinal dystrophy with early most likely 
congenital onset. Interviews with family elders revealed the 
initial presenting symptoms of night blindness and decreased 
visual acuity experienced by affected individuals in early 
childhood. We performed a detailed ophthalmic examination 
of selected individuals. Visual acuity in affected individuals 
21 and 30 was limited, progressing to only counting fingers 
in affected individual 21 (Table 1). The fundus examination 
of affected individual 21 shows severe bone spicule-like 
pigmentation in the mid-periphery and periphery of the retina 
along with milder macular involvement, arteriolar attenua-
tion, and disc pallor (Figure 2A). The fundus examination of 
affected individual 30 shows only milder macular involve-
ment, arteriolar attenuation, and disc pallor, and no bone 
spicule-like pigmentation was observed in the mid-periphery 
and periphery of the retina (Figure 2B). The affected individ-
uals had reduced ERG responses with delayed implicit time 
(Figure 3A–D). Photophobia or nystagmus was not observed 
in any affected or unaffected family member.
Initially, a genome-wide scan with 382 STR markers with 
an average spacing of approximately 10 cM was performed to 
localize the RP phenotype in PKRP133. Suggestive linkage 
with alleles of microsatellite markers on chromosome 5q, 
D5S422 and D5S400, was observed with LOD scores of 2.67 
and 2.24 at θ=0.05, respectively. Haplotype analysis identi-
fied a region distal to D5S636 based upon recombination in 
affected individual 17 excluding PDE6A that lies approxi-
mately 5 Mb proximal of D5S636. The causal haplotype in the 
critical interval was segregated with the disease phenotype 
within the family with the exception of individual 33 (age: 
24 years), who was homozygous for the disease haplotype 
(Figure 1). This individual was clinically evaluated over a 
period of 2 years, but no RP-like symptoms were observed. 
As shown in Figure 2, the fundus is normal with healthy 
retinal vasculature and the absence of any pigmentation in the 
peripheral and mid-peripheral regions of the retina (Figure 
2C-D). Similarly, ERG recordings show normal ranges of 
the a- and b-waves with normal implicit time (Figure 3E-H). 
Taken together, the clinical evaluations of individual 33 over 
the course of the study (Figure 2C–D and Figure 3E-H) 
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confirmed that this individual is clinically unaffected and 
does not exhibit any symptoms of RP.
In view of the clinical and haplotype analyses of indi-
vidual 33, an additional genome-wide linkage analysis was 
completed to rule out the possibility of additional evidence of 
linkage to a causal locus other than 5q33–35. Subsequently, 
a set of 399 additional markers were genotyped from the 
Linkage mapping set v.2.5-HD5, and taken together, all these 
markers refined the genome-wide resolution to approximately 
5 cM spacing across the entire genome. A two-point LOD 
score of 2.84 at θ=0 was obtained with marker D5S2066 
located distal to D5S422. Two-point LOD scores greater 
than 0.50 were also obtained for markers D3S3715, D5S471, 
D5S2115, D8S1771, D8S1820, D10S189, D13S173, D15S1002, 
D15S117, D16S3068, D16S503, D20S906, and D22S423. 
Linkage to all these markers was excluded either by large 
negative LOD scores calculated for closely flanking markers 
or by haplotype analysis.
Lack of identification of any potential locus other than 
on chromosome 5q during two separate genome-wide linkage 
scans and multiple clinical examinations of unaffected 
individual 33 that confirmed the absence of the clinical 
symptoms of RP prompted us to consider the following 
scenarios. First, affected individual 17 had been diagnosed 
Figure 1. Pedigree of family PKRP133. Squares are males, circles are females, filled symbols are affected individuals, the double line between 
individuals indicates consanguinity, and the diagonal line through a symbol is a deceased family member. The haplotypes of 14 adjacent 
chromosome 5q33 microsatellite markers are shown. The alleles that form the risk haplotype are shaded black and the alleles that do not 
cosegregate with RP are shown in white.
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incorrectly by the local ophthalmologist, and/or perhaps he 
manifested another form of retinal degeneration that had been 
misdiagnosed as RP. Second, affected individual 17 was a 
“phenocopy” manifesting the clinical phenotype of RP due 
to a genetic mutation not present on chromosome 5q. Initially, 
individual 17 voluntarily provided a blood sample; however, 
he has been reluctant to travel to an ophthalmology clinic 
for a thorough ocular examination. We approached affected 
individual 17 several times during the study and requested his 
cooperation for a comprehensive ocular examination without 
any success. Since we do not have conclusive evidence of the 
clinical phenotype, we redesignated his affectation status as 
“unknown.”
Subsequently, we genotyped additional STR markers 
proximal to D5S636, the previously defined proximal 
boundary of the critical interval. Lack of homozygosity 
in affected individuals 21, 27, and 29 at marker D5S2090 
suggested the causal mutation lies distal to marker D5S2090 
extending the critical interval with significant two-point LOD 
scores (Table 2). The new critical interval included PDE6A, 
a gene previously associated with RP. We sequenced all the 
coding exons, exon–intron boundaries along with the 5′ and 
3′ untranslated regions (UTRs) of PDE6A that identified a 
variation in intron 16 at the splice acceptor site substituting 
guanine for adenosine at position −1: c.2028–1G>A. The 
mutation segregated with disease phenotype in the family 
(Figure 1 and Figure 4A-C) except individual 17 (heterozy-
gous carrier of the c.2028–1G>A variation) and was absent in 
350 ethnically matched control chromosomes. This variation 
was not present in the 1000 Genomes and NHLBI Exome 
Sequencing Project databases.
We were confident that c.2028–1G>A is responsible for 
the RP phenotype in PKRP133 provided that (a) two genome 
scans localized the critical interval chromosome 5q, (b) 
PDE6A has been previously implicated in the pathogenesis 
of retinal dystrophies including RP, and (c) the splice acceptor 
site mutations at positions −1 and −2 are considered delete-
rious. Nonetheless, we sought additional evidence to exclude 
the possibility that a variant other than c.2028–1G>A present 
within the critical interval is responsible for the disease 
phenotype. We captured the entire exome of individual 29 
using the SureSelect Human All Exon Kit and sequenced 
on the Illumina HiSeq 2000 Genome Analyzer (Illumina). 
We identified 37 additional variants present within the 
critical interval excluding the splice-acceptor site variant 
(c.2028–1G>A) identified with Sanger sequencing; however, 
none of them satisfied the inclusion criterion of causality, 
which includes (a) absence or a low minor allele frequency in 
the 1000 Genomes and NHLBI Exome Sequencing Project 
databases; (b) absence from ethnically matched control chro-
mosomes; and (c) segregation with the disease phenotype in 
the respective family, further confirming that c.2028–1G>A 
is responsible for the RP phenotype in PKRP133.
Next, we interrogated our entire cohort of RP familial 
cases by genotyping STR markers that span the PDE6A 
followed by bidirectional sequencing of the coding exons and 
exon–intron boundaries. We identified an additional familial 
case, PKRP140 (Figure 4D), who harbored a splice acceptor 
site mutation in intron 10: c.1408–2A>G (Figure 4E-G). We 
recruited a total of 15 individuals of PKRP140; ten of these 
participating individuals manifested symptoms of RP. The 
splice acceptor mutation segregated with the disease pheno-
type (RP) in the family (Figure 4D-G) and was not found in 
350 ethnically matched control chromosomes and the 1000 
Genomes and NHLBI Exome Sequencing Project databases. 
We further evaluated the conservation of c.1408–2A and 
c.2028–1G in other PDE6A orthologs. As shown in Figure 5, 
c.1408–2A and c.2028–1G are fully conserved in primates, 
placental mammals, and vertebrate PDE6A orthologs.
We used HSF, a freely available online bioinformatics 
tool, to predict the effect of the c.1408–2A and c.2028–1G 
variations on PDE6A mRNA splicing. The HSF analysis 
Table 1. CliniCal CharaCTerisTiCs of members of family PKrP133.
ID Age 
(years)
Age at first 
diagnosis
First 
symptoms
Night 
blindness Fundus examination
ERG Visual Acuity
OD OS OD OS
21 55 Early childhood NB Progressive MD, Art.atten., Pig.dep PD
NAB, 
NF
NAB, 
NF C.F C.F
30 27 Early childhood NB
    
Progressive MD, Art.atten., Pig.dep PD
NAB, 
NF
NAB, 
NF 6/50 6/50
33 24 N/A Nil N/A Normal Normal Normal 6/6 6/6
41 27 N/A Nil N/A Normal Normal Normal 6/6 6/6
MD, macular degeneration; Art. atten, artery attenuation; Pig.dep, pigment deposit and PD, Pale optic disc. NAB: no ‘a’ or ‘b’ wave 
response; NF: no flicker response; OD and OS as defined in Figure 2.
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Figure 2. Fundus photographs of 
family PKRP133. A: OD and OS 
of individual 21. B: OD and OS 
of individual 30. C: OD and OS; 
individual 33 (examined at the 
age of 22 years). D: OD and OS 
of individual 33 (examined at the 
age of 24 years). E: OD and OS of 
individual 41. Fundus photographs 
of the affected individuals show 
attenuated arteries, bone spicule-
like pigmentation, and slightly 
tilted waxy optic discs. OD=oculus 
dexter (right eye); OS=oculus 
sinister (left eye).
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generated consensus values of 81.30 and 52.35 for the wild-
type (c.1408–2A) and mutant (of c.1408–2G) nucleotides, 
respectively. The predicted consensus deviation value of 
−35.61% for c.1408–2A>G suggests the loss of the wild-
type splice site that would result in the skipping of exon 11 
of PDE6A (Figure 6A). Likewise, HSF analysis predicted 
the consensus values of 82.23 and 53.28 for the wild-type 
(c.2028–1G) and mutant (c.2028–1A) nucleotides, respec-
tively. The predicted deviation of −35.21% for c.2028–1G>A 
suggests the loss of the wild-type splice acceptor site of 
exon 17 (Figure 6B-C). In parallel, HSF also detected the 
creation of a new cryptic splice acceptor site using the G 
nucleotide (c.2028G) in exon 17 (Figure 6D). The algorithm 
predicted consensus values of 45.37 and 74.31 for the wild-
type (c.2028–1G) and the new cryptic splice site (c.2028G), 
respectively. The predicted consensus value deviation of 
+63.81% for the new cryptic splice acceptor site suggests the 
loss of the wild-type splice site that would result in a frame-
shift and eventually would lead to a premature stop codon 
(p.K677Rfs24*) in the protein.
Figure 3. Electroretinography recordings of family PKRP133. Scotopic −25 dB, scotopic 0 dB response, and photopic 0 dB 30Hz flicker 
response of A) OD and B) OS of individual 21; C) OD and D) OS of individual 30; E) OD and F) OS of individual 33 (examined at the age 
of 22 years); G) OD and H) OS of individual 33 (examined at the age of 24 years); I) OD and J) OS of unaffected individual 41. Affected 
individuals 21 and 30 manifest typical retinitis pigmentosa (RP) changes on electroretinography (ERG), including loss of the rod and cone 
responses, while the ERG readings of unaffected individuals 33 and 41 show normal rod and cone responses. OD=oculus dexter (right eye); 
OS=oculus sinister (left eye).
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DISCUSSION
We report in this study two splicing acceptor site mutations in 
PDE6A associated with autosomal recessive RP in two large 
consanguineous Pakistani families. Two-point LOD scores of 
3.66 and 3.17 for markers D5S2026 and D5S636, respectively, 
the absence of any scores >1.5 observed during genome-wide 
linkage scan other than on 5q, identification of variations in 
evolutionary conserved bases, c.1408–2A and c.2028–1G, 
and the absence of these variations in ethnically matched 
control chromosomes, 1000 Genomes and NHLBI Exome 
Sequencing Project databases strongly support our conclusion 
that the two splice acceptor site mutations are responsible for 
the retinal phenotype of the patients reported in this study.
In silico analysis predicted that a splice-site mutation 
(c.1408–2A>G) would destroy the splice acceptor site, which 
would result in the skipping of exon 11. Exon 11 consists of 
66 base pairs, and thus, skipping of exon 11 would introduce 
the deletion of 22 amino acids (p.K470_L491del) without 
disturbing the reading frame of PDE6A. The simple modular 
architecture research tool (SMART) identified two cGMP-
specific phosphodiesterases, adenylyl cyclases and FhlA 
(GAF) domains (73–232 and 254–441 amino acids), two 
low-complexity regions (478–495 and 823–851 amino acids), 
and one PDEase catalytic domain (3′5′-cyclic nucleotide phos-
phodiesterase) ranging from 556 to 734 amino acids. Based 
on the PDE6A protein domain structure, this deletion will 
eliminate the low-complexity region (478–495 amino acids).
However, two possible scenarios are predicted for the 
splice site c.2028–1G>A mutation: (a) the creation of a new 
cryptic splice acceptor site using the first G nucleotide of 
exon 17 and (b) the less likely scenario of the complete skip-
ping of exon 17. The inclusion of this cryptic acceptor site 
would lead to a frameshift and would ultimately result in 
a premature termination: p.K677Rfs24* (Figure 6D). The 
mutant mRNA would be degraded by the nonsense mediated 
decay (NMD) pathway. Even if the protein escapes the NMD 
pathway, the truncated protein would lack 160 C-terminal 
amino acids including the cGMP-binding site and one 
low-complexity region. However, skipping exon 17, which 
comprises 108 bp, would result in a deletion composed of 36 
amino acids (p.K676_M712del) without altering the reading 
frame of PDE6A but would disrupt the PDEase catalytic 
domain (Figure 6D).
To date, 20 causal mutations in PDE6A have been asso-
ciated with RP including ten missense, five nonsense, two 
splice site, two frameshift, and a deletion encompassing the 
entire gene [14,15,20–26]. Dryja and colleagues screened 
sporadic and recessive RP cases and found that mutations 
in PDE6A are responsible for the clinical phenotype in 3% 
of Caucasian patients [21]. Previously, our group identified 
mutations in PDE6A in three consanguineous families [15]. 
Taking these results together, we have identified five families 
in our cohort of >300 familial cases suggesting an approxi-
mate 2% contribution to the total genetic load of RP.
Table 2. Two-PoinT loD sCores of Chromosome 5q marKers for family PKrP133.
Marker cM Mb 0 0.01 0.05 0.1 0.2 0.3 Zmax θmax
D5S2090 150.34 147.22 −3.32 0.24 0.85 0.98 0.83 0.51 0.98 0.10
D5S636 153.17 149.89 3.17 3.11 2.86 2.52 1.80 1.09 3.17 0.00
D5S2026 157.41 153.86 3.66 3.60 3.35 3.00 2.23 1.39 3.66 0.00
D5S1507 157.57 155.24 - ∞ 2.3 2.65 2.5 1.88 1.18 2.65 0.05
D5S2852 158.12 155.42 - ∞ 2.32 2.66 2.53 1.89 1.21 2.66 0.05
D5S1971 161.94 158.54 ∞ 0.66 1.1 1.09 0.77 0.4 1.1 0.05
D5S422* 164.19 162.15 - ∞ 2.33 2.67 2.52 1.91 1.18 2.67 0.05
D5S2066 165.13 163.35 2.84 2.77 2.52 2.2 1.54 0.88 2.84 0.00
D5S2050* 171.06 166.51 - ∞ 2.28 2.64 2.5 1.87 1.1 2.64 0.05
D5S400* 174.80 168.44 - ∞ 1.84 2.24 2.16 1.67 1.06 2.24 0.05
D5S625 177.06 170.17 - ∞ 2.11 2.46 2.32 1.75 1.09 2.46 0.05
D5S1960$ 179.11 171.51 - ∞ 2.6 2.95 2.81 2.19 1.4 2.95 0.05
D5S2069 182.35 173.10 - ∞ 1.84 2.32 2.27 1.78 1.1 2.32 0.05
D5S2111 187.81 176.04 - ∞ 0.1 1.17 1.35 1.14 0.71 1.35 0.1
Asterisk (*) and dollar ($) symbols indicate the markers included in genome-wide scan using Linkage mapping set v.2.5-HD10 and HD5, 
respectively. Linkage analysis was performed with alleles of PKRP133 using the FASTLINK version of MLINK while maximum LOD 
scores were calculated using ILINK from the LINKAGE Program Package.
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Figure 4. Causal variants in PDE6A 
identified in families PKRP133 and 
PKRP140. A: Sequence chromato-
gram of unaffected individual 15 
homozygous for the wild-type. B: 
Sequence chromatogram of unaf-
fected individual 28 heterozygous 
carriers. C: Sequence chromato-
gram of affected individual 29 
of PKRP133 homozygous for 
the G to A variation in intron 16; 
c.2028–1G>A. D: Pedigree of 
family PKRP140 with the haplo-
types of four adjacent chromosome 
5q33 microsatellite markers are 
shown with the alleles forming 
the risk haplotype shaded black 
and the wild-type allele shown in 
white. Squares are males, circles 
are females, filled symbols are 
affected individuals, the double 
line between individuals indicates 
consanguinity, and the diagonal 
line through a symbol is a deceased 
family member. E: Sequence chro-
matogram of unaffected control 
homozygous for the wild-type. 
F: Sequence chromatogram of 
individual 13 heterozygous carrier. 
G: Sequence chromatogram of 
affected individual 14 of PKRP140 
homozygous for the A to G transi-
tion in intron 10: c.1408–2A>G. 
The arrows point to the splice 
site variation identified in fami-
lies PKRP133 (c.2028–1G) and 
PRKP140 (c.1408–2A) whereas 
green, red, and brown represent 
the exon, splice acceptor site, and 
intron, respectively. SA=splice 
acceptor.
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Figure 5. Sequence alignment illustrating the conservations of PDE6A splice acceptor sites. c.2028–1G and c.1408–2A are fully conserved 
in the PDE6A orthologs. The organisms in brown and blue are primates and placental mammals, respectively, and the c.2028–1G and 
c.1408–2A variations are in red.
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In conclusion, we identified two splice acceptor site 
mutations segregated in two large consanguineous pedigrees 
responsible for arRP. The identification of causal mutations 
will enhance diagnostic capabilities leading to the identifica-
tion of carrier status, which would help in the prevention of 
the familial form of arRP.
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